Publication | Closed Access

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

Hepatitis CMulticentre Phase 2Viral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyAntiviral DrugMedicinePegylated Interferon Alfa-2aTreatment-naive Patients